EX-23.1 4 a202110-kexhibit231.htm EX-23.1

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the registration statements (Nos. 333-262403 and 333-262404) on Form S-3 and (No. 333-260068) on Form S-8 of our report dated March 11, 2022, with respect to the consolidated financial statements of Xeris Biopharma Holdings, Inc.

/s/ KPMG LLP

Chicago, Illinois

March 11, 2022